Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 31 min ago
Peer-reviewedLicence not statedJournal of Diabetes and Metabolic Disorders

Efficacy and safety of semaglutide versus placebo in adults with overweight or obesity without diabetes: updated meta-analysis of randomized trials

  • Rida Wajid1
  • Ravi Kumar2
  • Misbah Muneer3
  • Maria Nauroz Ali4
  • Jazia Ul Mustafa5
  • Javeria Qamar6
  • Daniyal Asif7
  • Saadia Ziaulhaque8
  • Iqra Sohail9
  • Fawaz Ahmed Khamisani10
  • Maria Noureen11
  • Sadaf Fatima12
3 more authors
  • Ali Saqlain13
  • Laksh Kumar14
  • Adarsh Raja14
14 affiliations
  1. 1Department of Internal Medicine, King Edward Medical University, Lahore, Pakistan
  2. 2Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan
  3. 3Nishtar Medical University, Multan, Pakistan
  4. 4Lahore General Hospital, Lahore, Pakistan
  5. 5FMH College of Medicine and Dentistry, Lahore, Pakistan
  6. 6Civil Hospital, Karachi, Pakistan
  7. 7Shihezi University School of Medicine, Xinjiang, China
  8. 8Akhtar Saeed Medical and Dental College, Lahore, Pakistan
  9. 9Bahria University Health Sciences Campus, Karachi, Pakistan
  10. 10Ziauddin University, Karachi, Pakistan
  11. 11Rawalpindi Medical University, Rawalpindi, Pakistan
  12. 12Bakhtawar Ameen Medical and Dental College, Multan, Pakistan
  13. 13Asian Medical Institute, Kant, Kyrgyzstan
  14. 14Department of Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan
Read full textDOICite

Related

  1. Short-term clinical efficacy and recorded adverse events of semaglutide combined with dapagliflozin in patients with type 2 diabetes mellitus and chronic kidney disease
    Cheng Gong, Qiong Luo, Qin Li
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial
    Chloe Stanley, Ritwika Mallik, Nausheen Hamid +20
    Nature MedicinePeer-reviewedCC BYFull text14 citedSurgery & anaesthesiaOpenAlex
  3. Durability of Semaglutide Effects After Treatment Discontinuation in HIV-Associated Lipohypertrophy: A Randomized, Double-Blind, Placebo-Controlled Phase 2b Clinical Trial.
    Ruth O Adekunle, Qian Wu, Abdus Sattar +5
    Open forum infectious diseasesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. CagriSema versus Semaglutide 2.4 mg monotherapy for weight management in adults with overweight or obesity, with or without type 2 diabetes: a systematic review, meta-analysis, and trial sequential analysis
    Zehra Khatoon Rasool, Rajvi Shah, Ansharah E Zinnia Batool +8
    Frontiers in endocrinologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMCCrossref
  5. CLB101TM Improves Gastrointestinal Symptom Burden in Overweight Adults: A Randomized, Double-Blind, Placebo-Controlled Study
    A. D. Grant, B. Meehan, M. C. E. Krupa +9
    medRxivPreprintCC BY-NC-NDFull textGeneral medicinemedRxiv

Cite

BibTeXRIS
BibTeX
@article{wajid2026efficacy,
  title = {{Efficacy and safety of semaglutide versus placebo in adults with overweight or obesity without diabetes: updated meta-analysis of randomized trials}},
  author = {Rida Wajid and Ravi Kumar and Misbah Muneer and Maria Nauroz Ali and Jazia Ul Mustafa and Javeria Qamar and Daniyal Asif and Saadia Ziaulhaque and Iqra Sohail and Fawaz Ahmed Khamisani and Maria Noureen and Sadaf Fatima and Ali Saqlain and Laksh Kumar and Adarsh Raja},
  journal = {Journal of Diabetes and Metabolic Disorders},
  year = {2026},
  month = oct,
  doi = {10.1007/s40200-026-02108-x},
  url = {https://doi.org/10.1007/s40200-026-02108-x},
}
RIS
TY  - JOUR
TI  - Efficacy and safety of semaglutide versus placebo in adults with overweight or obesity without diabetes: updated meta-analysis of randomized trials
AU  - Rida Wajid
AU  - Ravi Kumar
AU  - Misbah Muneer
AU  - Maria Nauroz Ali
AU  - Jazia Ul Mustafa
AU  - Javeria Qamar
AU  - Daniyal Asif
AU  - Saadia Ziaulhaque
AU  - Iqra Sohail
AU  - Fawaz Ahmed Khamisani
AU  - Maria Noureen
AU  - Sadaf Fatima
AU  - Ali Saqlain
AU  - Laksh Kumar
AU  - Adarsh Raja
PY  - 2026
DA  - 2026/10/31
JO  - Journal of Diabetes and Metabolic Disorders
DO  - 10.1007/s40200-026-02108-x
UR  - https://doi.org/10.1007/s40200-026-02108-x
SN  - 2251-6581
ER  -